BioWorld

Cyted gets FDA approval for capsule sponge device

Cyted Ltd. received U.S. FDA 510(k) clearance for its Endosign capsule technology, a non-endoscopic capsule sponge device used to collect pan-esophageal samples to detect esophageal pre-cancer and ...
Healio

Cyted snags FDA 510(k) clearance for non-endoscopic esophageal precancer test

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA granted 510(k) clearance to Cyted’s EndoSign, a ...
Healio

Capsule-sponge test could replace endoscopy in surveillance of low-risk Barrett’s esophagus

Please provide your email address to receive an email when new articles are posted on . A capsule-sponge test may help risk-stratify patients with Barrett’s esophagus. Patients classified as low risk ...
Medscape

Less Invasive Sponge Test Stratifies Risk in Patients With Barrett Esophagus

Capsule sponge-based surveillance could be used in lieu of endoscopy for low-risk Barrett esophagus (BE) surveillance, a prospective multisite UK study found. The biomarker risk panel collected by the ...
clinicaladvisor.com

Capsule Sponge + Biomarkers Can Stratify Risk in Barrett Esophagus

The researchers found that in the high-risk patient group, the positive predictive value for any dysplasia or worse was 37.7%. HealthDay News — In adult patients with nondysplastic Barrett esophagus ...
Hosted on MSN

Cyted raises $44m to propel US market expansion of its endoscopic capsule

UK-based Cyted Health has raised $44m to accelerate the ongoing market adoption of its EndoSign device in the US. The gastrointestinal (GI) diagnostic company’s EndoSign is a swallowable ‘capsule ...